Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Obsidian Therapeutics, Inc.OBX · Entity 4898 | Director | August 03, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Obsidian Therapeutics, Inc.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.00 · Expires 2036-08-02 | Direct | 37,653 |
Reported balance
After 2026-08-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-03 · Grant · Acquired 37,653 · Balance 37,653 F1: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Generation Bio Co.
Report date January 10, 2025 · Filed January 10, 2025
Section 16 reporting ended · disclosed 2025-01-10. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 5, 2026 20:08 UTC | Obsidian Therapeutics, Inc. OBX · Entity 4898 | GrantStock Option (Right to Buy) · Derivative | 37,653 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0001193125-26-335083 · ownership.xml · derivative · entry 1 Norkunas Matthew · CIK 0001816836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,653 Underlying: Common Stock · 37,653 shares Expires 2036-08-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-025336 · form4-10172024_041008.xml · derivative · entry 6 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,673 Underlying: Common Stock · 1,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-025336 · form4-10172024_041008.xml · derivative · entry 5 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,059 Underlying: Common Stock · 1,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $2.42 | $1,190.64 |
DisclosureSEC source: 0001415889-24-025336 · form4-10172024_041008.xml · nonDerivative · entry 4 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,348 Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-025336 · form4-10172024_041008.xml · nonDerivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $2.42 | $1,190.64 |
DisclosureSEC source: 0001415889-24-025336 · form4-10172024_041008.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,167 Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-025336 · form4-10172024_041008.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019650 · form4-07172024_040713.xml · derivative · entry 6 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,346 Underlying: Common Stock · 1,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019650 · form4-07172024_040713.xml · derivative · entry 5 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,733 Underlying: Common Stock · 1,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $2.93 | $1,441.56 |
DisclosureSEC source: 0001415889-24-019650 · form4-07172024_040713.xml · nonDerivative · entry 4 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,985 Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-019650 · form4-07172024_040713.xml · nonDerivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $2.93 | $1,441.56 |
DisclosureSEC source: 0001415889-24-019650 · form4-07172024_040713.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,804 Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:05 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-019650 · form4-07172024_040713.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:10 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011040 · form4-04172024_050408.xml · derivative · entry 6 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,019 Underlying: Common Stock · 1,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:10 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011040 · form4-04172024_050408.xml · derivative · entry 5 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,407 Underlying: Common Stock · 1,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:10 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $3.70 | $1,820.40 |
DisclosureSEC source: 0001415889-24-011040 · form4-04172024_050408.xml · nonDerivative · entry 4 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,622 Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:10 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011040 · form4-04172024_050408.xml · nonDerivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:10 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $3.70 | $1,820.40 |
DisclosureSEC source: 0001415889-24-011040 · form4-04172024_050408.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,441 Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:10 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011040 · form4-04172024_050408.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · derivative · entry 9 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,692 Underlying: Common Stock · 1,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F4 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 6,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · derivative · entry 8 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,081 Underlying: Common Stock · 6,694 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 7,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · derivative · entry 7 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 581 | $1.91 | $1,109.71 |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · nonDerivative · entry 6 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,259 Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · nonDerivative · entry 5 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 2,320 | $1.91 | $4,431.20 |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · nonDerivative · entry 4 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,166 Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 6,694 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · nonDerivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 2,577 | $1.91 | $4,922.07 |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,792 Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 7,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001329 · form4-01172024_050105.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:35 UTC | Generation Bio Co. GBIO · Entity 67174 | GrantStock Option (right to buy) · Derivative | 160,650 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001415889-24-000301 · form4-01032024_040112.xml · derivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,650 Underlying: Common Stock · 160,650 shares Expires 2034-01-01 F1 · derivative.exercise_date: The option to purchase 160,650 shares of common stock was granted on January 2, 2024. The shares underlying the option vest over four years, with 25% of the shares vesting on January 2, 2025 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:30 UTC | Generation Bio Co. GBIO · Entity 67174 | GrantStock Option (right to buy) · Derivative | 76,310 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-23-015860 · form4-12052023_041211.xml · derivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,310 Underlying: Common Stock · 76,310 shares Expires 2033-11-30 F1 · derivative.exercise_date: The option to purchase 76,310 shares of common stock was granted on December 1, 2023. The shares underlying the option vest over two years, with 25% of the shares vesting on June 1, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014359 · form4-10172023_061008.xml · derivative · entry 6 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,366 Underlying: Common Stock · 1,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 7,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014359 · form4-10172023_061008.xml · derivative · entry 5 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,437 Underlying: Common Stock · 7,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 492 | $3.24 | $1,594.08 |
DisclosureSEC source: 0001415889-23-014359 · form4-10172023_061008.xml · nonDerivative · entry 4 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,932 Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 1,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-014359 · form4-10172023_061008.xml · nonDerivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 2,183 | $3.24 | $7,072.92 |
DisclosureSEC source: 0001415889-23-014359 · form4-10172023_061008.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,750 Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 22:00 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 7,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-014359 · form4-10172023_061008.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:35 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 3,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011234 · form4-07182023_040706.xml · derivative · entry 6 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,040 Underlying: Common Stock · 3,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:35 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 7,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011234 · form4-07182023_040706.xml · derivative · entry 5 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,874 Underlying: Common Stock · 7,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:35 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 983 | $5.08 | $4,993.64 |
DisclosureSEC source: 0001415889-23-011234 · form4-07182023_040706.xml · nonDerivative · entry 4 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,496 Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:35 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 3,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-011234 · form4-07182023_040706.xml · nonDerivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:35 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 2,183 | $5.08 | $11,089.64 |
DisclosureSEC source: 0001415889-23-011234 · form4-07182023_040706.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,131 Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 20:35 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 7,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-011234 · form4-07182023_040706.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 20:17 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 7,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006599 · form4-04182023_080446.xml · derivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,311 Underlying: Common Stock · 7,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 20:17 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 2,183 | $4.50 | $9,823.50 |
DisclosureSEC source: 0001415889-23-006599 · form4-04182023_080446.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,877 Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 20:17 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionCommon Stock | 7,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-006599 · form4-04182023_080446.xml · nonDerivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:06 UTC | Generation Bio Co. GBIO · Entity 67174 | GrantRestricted Stock Units · Derivative | 13,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-001355 · form4-01242023_090144.xml · derivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,388 Underlying: Common Stock · 13,388 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F4 · derivative.exercise_date: The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:06 UTC | Generation Bio Co. GBIO · Entity 67174 | GrantRestricted Stock Units · Derivative | 26,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-001355 · form4-01242023_090144.xml · derivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,775 Underlying: Common Stock · 26,775 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F3 · derivative.exercise_date: The shares underlying the restricted stock units vest over four years, with 25% of the shares vesting on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. F3 · derivative.expiration_date: The shares underlying the restricted stock units vest over four years, with 25% of the shares vesting on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:06 UTC | Generation Bio Co. GBIO · Entity 67174 | GrantStock Option (right to buy) · Derivative | 53,550 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001415889-23-001355 · form4-01242023_090144.xml · derivative · entry 1 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,550 Underlying: Common Stock · 53,550 shares Expires 2033-01-20 F1 · derivative.exercise_date: This option was granted on January 20, 2023. The shares underlying the option vest over four years, with 25% of the shares vesting on January 20, 2024 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:57 UTC | Generation Bio Co. GBIO · Entity 67174 | Exercise / conversionRestricted Stock Units · Derivative | 7,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-001078 · form4-01182023_090137.xml · derivative · entry 3 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,748 Underlying: Common Stock · 7,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock. F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 21:57 UTC | Generation Bio Co. GBIO · Entity 67174 | Tax withholdingCommon Stock | 2,578 | $5.10 | $13,147.80 |
DisclosureSEC source: 0001415889-23-001078 · form4-01182023_090137.xml · nonDerivative · entry 2 Norkunas Matthew · CIK 0001816836 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,623 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.